SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-20-000082
Filing Date
2020-09-30
Accepted
2020-09-30 12:10:35
Documents
83
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10kvedgar6.htm 10-K 618552
2 sgbi10k2020audit20200928v1.jpg GRAPHIC 13943
3 sgbi10k2020audit20200928v2.jpg GRAPHIC 25270
4 21.1.htm EX-21 2029
5 0001551163-20-000082-3101.htm EX-31 7979
6 0001551163-20-000082-3102.htm EX-31 8072
  Complete submission text file 0001551163-20-000082.txt   2898839

Data Files

Seq Description Document Type Size
7 sgbi-20200630.xml EX-101.INS 392902
8 sgbi-20200630.xsd EX-101.SCH 38550
9 sgbi-20200630_cal.xml EX-101.CAL 28307
10 sgbi-20200630_def.xml EX-101.DEF 96983
11 sgbi-20200630_lab.xml EX-101.LAB 190026
12 sgbi-20200630_pre.xml EX-101.PRE 195778
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-29233 | Film No.: 201211461
SIC: 2834 Pharmaceutical Preparations